Last reviewed · How we verify
Synergy for Staphylococcus Skin and Skin Structure Infection
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Gentamicin · Merck & Co.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Synergy for Staphylococcus Skin and Skin Structure Infection patent landscape — cliff calendar, originator estates, attackable patents
- Synergy for Staphylococcus Skin and Skin Structure Infection treatment landscape brief
- Synergy for Staphylococcus Skin and Skin Structure Infection treatment updates RSS
Frequently asked questions about Synergy for Staphylococcus Skin and Skin Structure Infection
What drugs treat Synergy for Staphylococcus Skin and Skin Structure Infection?
Tracked treatments include Ramycin, Garamycin, Gentamicin.
What is the treatment for Synergy for Staphylococcus Skin and Skin Structure Infection?
Standard treatment for Synergy for Staphylococcus Skin and Skin Structure Infection includes Ramycin, Garamycin, Gentamicin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Synergy for Staphylococcus Skin and Skin Structure Infection patent cliff · Synergy for Staphylococcus Skin and Skin Structure Infection CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Gentamicin · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing